I’m not worried about a seller at 155c. If we get anywhere close to 155c ($1.55) I will be a very happy shareholder indeed.
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial